Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
148
datasets available to search
ShareScore release 0.9.0
Dataset results
148 results for “vemurafenib”
Honokiol Bis-Dichloroacetate (Honokiol DCA) Demonstrates Activity in Vemurafenib-Resistant Melanoma in Vivo.
GEO Series GSE76956. Homo sapiens. 9 samples. Type: Expression profiling by array.
Melanoma GEMM Tumors, untreated or vemurafenib treated
GEO Series GSE205294. Mus musculus. 37 samples. Type: Expression profiling by high throughput sequencing.
Figure 3 from: Neamah MJ, Al-Akkam EJM (2024) Preparation and characterization of vemurafenib microemulsion based hydrogel using surface active ionic liquid. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e111178
Figure 3 Rheological behaviour of different microemulsion-based hydrogel formulas.
Figure 2 from: Neamah MJ, Al-Akkam EJM (2024) Preparation and characterization of vemurafenib microemulsion based hydrogel using surface active ionic liquid. Pharmacia 71: 1-9. https://doi.org/10.3897/pharmacia.71.e111178
Figure 2 Release profile of vemurafenib from different SAIL-based microemulsion formulas.
Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant Melanoma
ClinicalTrials.gov study NCT02077114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma
ClinicalTrials.gov study NCT01898585. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600
ClinicalTrials.gov study NCT02902029. IPD Sharing: NO. Countries: 4. Publications: 0.
XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
ClinicalTrials.gov study NCT02721459. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study
ClinicalTrials.gov study NCT02052193. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation
ClinicalTrials.gov study NCT05263453. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib
ClinicalTrials.gov study NCT02115035. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
ClinicalTrials.gov study NCT01709292. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-seeking Study of Pembrolizumab Plus Vemurafenib and Cobimetinib Advanced Melanoma
ClinicalTrials.gov study NCT02818023. IPD Sharing: NO. Countries: 1. Publications: 0.
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
ClinicalTrials.gov study NCT06440850. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma
ClinicalTrials.gov study NCT01616199. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
ClinicalTrials.gov study NCT01611675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer
ClinicalTrials.gov study NCT01596140. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiation Use During Vemurafenib Treatment
ClinicalTrials.gov study NCT01843738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma
ClinicalTrials.gov study NCT03005639. IPD Sharing: NO. Countries: 1. Publications: 0.
To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progres
ClinicalTrials.gov study NCT03514901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.